Cost and Value in Contemporary Heart Failure Clinical Guidance Documents

John W. Ostrominski(Brigham and Women's Hospital), Muthiah Vaduganathan(Harvard University), Paul A. Heidenreich(American Heart Association), Thomas M. Maddox(BJC HealthCare), James L. Januzzi(Harvard University), Mona Fiuzat(Duke University), Ankeet S. Bhatt(Brigham and Women's Hospital), Carolyn S.P. Lam, Gregg C. Fonarow, Sameer Hirji(Harvard University), Christopher M. O’Connor(Alaska Heart and Vascular Institute), Javed Butler(University of Mississippi Medical Center)

JACC Heart Failure

November 10, 2021

10.1016/j.jchf.2021.08.002

Cited by 18

Related Papers

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

|Circulation|2019|6.2k

Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction

|Circulation|2010|4.8k

Empagliflozin in Heart Failure with a Preserved Ejection Fraction

|New England Journal of Medicine|2021|4.6k

Forecasting the Future of Cardiovascular Disease in the United States

|Circulation|2011|3.2k

Forecasting the Impact of Heart Failure in the United States

|Circulation Heart Failure|2013|2.8k